The effect of aerobic exercise at home and turmeric supplementation in type 2 diabetes during Covid -19 quarantine

The effect of eight weeks of home aerobic exercise and turmeric supplementation on anthropometric indices, glycemic status, lipid profile and quality of life in middle-aged women with type 2 diabetes during Covid -19 quarantine

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201129049524N1

Enrollment

Registered

2021-05-26

Start date

2021-06-15

Completion date

Unknown

Last updated

2021-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes

Interventions

Intervention 1: Intervention group: Intervention group: Aerobic exercise group (10 people), 8 weeks of aerobic exercise with 3 sessions per week online, the first week with an intensity of 60% of maxi

Thus, during the first 4 weeks with 60% of maximum heart rate for 30 minutes and 3 days per week and during the second 4 weeks with 75% of maximum heart rate for 45 minutes and 3 days per week. Interv

During the first 4 weeks with 60% of maximum heart rate for 30 minutes and 3 days a week and during the second 4 weeks with 75% of maximum heart rate for 45 minutes and 3 days a week and turmeric supp

Eligibility

Sex/Gender

Female

Age

40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Non-insulin type 2 diabetes HbA1C above 6 TG above 150 mg / dL LDL above 100 mg / dL Do not take antioxidants, multivitamin supplements and polyphenols in the last three months Overweight body mass index (25 to 29.99 kg / m2)

Exclusion criteria

Exclusion criteria: Change in the amount and type of medication used Physical activity and diet during the study period Fasting blood sugar greater than 200 mg / dL LDL greater than 160 mg / dL Acute heart disease, kidney, liver and thyroid failure Severe gastrointestinal diseases and gastric ulcer Gallstones Pregnancy or breastfeeding

Design outcomes

Primary

Measure	Time frame
Lipid profile. Timepoint: Before the intervention and after the end of the study. Method of measurement: Using a blood test.;Glycemic indexes. Timepoint: Before the intervention and after the end of the study. Method of measurement: Using a blood test.;Anthropometric indicators. Timepoint: Before the intervention and after the end of the study. Method of measurement: With little measuring tools.;Quality of Life. Timepoint: Before the intervention and after the end of the study. Method of measurement: questionnaire.	—

Measure

Time frame

Lipid profile. Timepoint: Before the intervention and after the end of the study. Method of measurement: Using a blood test.;Glycemic indexes. Timepoint: Before the intervention and after the end of the study. Method of measurement: Using a blood test.;Anthropometric indicators. Timepoint: Before the intervention and after the end of the study. Method of measurement: With little measuring tools.;Quality of Life. Timepoint: Before the intervention and after the end of the study. Method of measurement: questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRastegar Hosseini

Razi University of Kermanshah

Rastegar.hoseini@gmail.com+98 83 3423 3267

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026